China's emphasis on innovation and development in the pharmaceutical sector is driving expansion for global giants like Bayer. Leveraging initiatives such as intelligent manufacturing in areas like the Beijing Economic-Technological Development Area, foreign investors are increasing their investments in the country's pharmaceutical industry. This growth reflects China's commitment to fostering an environment conducive to pharmaceutical innovation and production.